Lifecore Biomedical Inc.

NASDAQ: LFCR · Real-Time Price · USD
7.37
-0.05 (-0.67%)
At close: Aug 15, 2025, 3:59 PM
7.37
0.07%
After-hours: Aug 15, 2025, 04:10 PM EDT

Lifecore Biomedical Income Statement

Financials in USD. Fiscal year is June - May.
Fiscal Year Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending May 25, 2025 Feb 23, 2025 Nov 24, 2024 Aug 25, 2024 May 26, 2024 Feb 25, 2024 Nov 26, 2023 Aug 27, 2023 May 28, 2023 Feb 26, 2023 Nov 27, 2022 Aug 28, 2022 May 29, 2022 Feb 28, 2022 Nov 30, 2021 Aug 31, 2021 May 31, 2021 Feb 28, 2021 Nov 30, 2020 Aug 31, 2020
Revenue
128.87M 130.31M 130.86M 128.44M 128.26M 121.92M 112.75M 104.47M 123.3M 139.38M 165.92M 273.55M 358.98M 451.19M 535.89M 537.31M 544.16M 560.46M 575.61M 587.29M
Cost of Revenue
88.57M 86.72M 85.22M 83.94M 86.41M 88.95M 83.13M 79.12M 94.43M 107.39M 128.59M 228.9M 303.07M 381.98M 460.89M 454.66M 462.69M 479.7M 494.48M 511.3M
Gross Profit
40.3M 43.59M 45.64M 44.51M 41.85M 32.97M 29.62M 25.35M 28.87M 31.99M 37.33M 44.65M 55.91M 69.21M 75M 82.65M 81.47M 80.76M 81.12M 76M
Operating Income
-19.67M -20.42M -11.52M -10.88M -7.92M -15.1M -21.51M -25.53M -23.37M -24.31M -21.53M -19.64M -16.99M -9.79M -6.83M -4.84M -13.5M -27.84M -42.06M -46.63M
Interest Income
n/a n/a n/a n/a n/a 15K 37K 53K 68K 68K 66K 69K 81K 83K 76K 67K 48K 37K 70K 85K
Pretax Income
-38.67M -44.7M -14.92M 5.78M 9.51M -16.91M -43.18M -66.55M -65.38M -68.2M -64.33M -96.39M -96.64M -63.68M -62.01M -36.75M -40.47M -57.45M -68.56M -60.47M
Net Income
-38.72M -44.65M -14.25M 6.54M 12.01M -17.03M -69.17M -96.2M -96.79M -97.14M -73.48M -99.11M -97.24M -63.64M -56.28M -31.14M -32.67M -44.95M -50.97M -44.41M
Selling & General & Admin
44.49M 47.74M 47.49M 45.56M 40.46M 39.92M 40.36M 41.94M 43.4M 47.14M 46.58M 49.64M 54.92M 55.63M 61.13M 63.4M 65.36M 67.42M 70.98M 73.6M
Research & Development
8.26M 8.32M 8.44M 8.62M 8.57M 8.53M 8.59M 8.61M 8.52M 8.46M 8.28M 8.88M 9.66M 10.18M 10.69M 10.54M 10.22M 10.35M 10.54M 10.79M
Other Expenses
7.22M 7.22M 483K 483K n/a n/a 2.57M 2.57M 2.57M 2.57M n/a 79K 188K 234K 306K 227K 97K 51K 46K 40K
Operating Expenses
59.97M 63.27M 56.42M 54.66M 49.04M 48.45M 51.52M 50.7M 52.06M 55.73M 52.44M 58.52M 64.58M 65.81M 71.81M 73.94M 75.59M 77.77M 81.52M 84.39M
Interest Expense
21.84M 22.1M 20.91M 19.52M 18.09M 16.23M 16.78M 16.31M 16.05M 15.6M 14.87M 14.36M 17.36M 18.89M 17.73M 17.67M 14.11M 12.23M 11.51M 10.63M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a 5.1K 5.1K 5.1K 5.1K 5.6K 5.6K 5.6K 5.6K 100K 100K 100K 100K 1.8M 1.8M 1.8M
Cost & Expenses
148.54M 150.73M 143.15M 140.1M 136.96M 138.18M 134.65M 129.82M 146.49M 163.13M 181.02M 287.42M 367.64M 447.79M 532.71M 528.6M 538.27M 557.46M 576M 595.68M
Income Tax Expense
43K -47K 178K 70K 183K 463K 316K 385K 301K -440K -786K -3.61M -5.73M -5.79M -5.73M -5.6M -7.8M -12.5M -17.59M -16.06M
Shares Outstanding (Basic)
37.03M 37.02M 34.36M 30.86M 30.56M 30.49M 30.46M 30.4M 30.32M 30.3M 30.3M 29.58M 29.51M 28.86M 29.47M 29.36M 29.33M 29.3M 28.34M 28.95M
Shares Outstanding (Diluted)
37.03M 37.02M 34.36M 30.86M 30.56M 36.61M 36.42M 30.4M 30.32M 30.3M 30.3M 29.58M 29.51M 29.48M 29.47M 29.42M 29.33M 29.32M 29.28M 29.24M
EPS (Basic)
-1.31 -1.48 -0.5 0.22 0.40 -0.56 -2.27 -3.16 -3.19 -3.24 -2.49 -3.37 -3.31 -2.17 -1.91 -1.08 -1.14 -1.56 -1.76 -1.52
EPS (Diluted)
-1.31 -1.48 -0.58 0.06 0.24 -0.72 -2.35 -3.16 -3.19 -3.24 -2.48 -3.36 -3.3 -2.16 -1.91 -1.06 -1.12 -1.54 -1.74 -1.52
EBITDA
-8.81M -10.49M 18.02M 37.06M 39.54M 7.97M -16.54M -39.2M -32.77M -35.96M -33.19M -62.24M -60.88M -24.62M -21.31M 1.72M -6.76M -25.32M -38.15M -30.8M
EBIT
-16.84M -22.6M 5.99M 25.3M 27.6M 3.6M -22.12M -45.96M -40.85M -48.5M -44.7M -76.04M -76.24M -41.65M -40.57M -16.6M -25.12M -43.98M -57.06M -49.83M
Depreciation & Amortization
8.03M 7.87M 7.79M 7.52M 7.69M 8.12M 9.33M 10.5M 12.28M 13M 12.62M 14.91M 16.02M 17.69M 19.25M 18.31M 18.36M 18.83M 19.2M 19.44M